Colgate Weathers Slowing Emerging Markets, Sees ‘Encouraging’ Signs
This article was originally published in The Rose Sheet
Slower growth in emerging markets – especially Brazil and China – impacted Colgate’s third-quarter financial performance, but the firm is optimistic that it is seeing signs of a reversal in China and Brazil. Overall sales dipped slightly on a reported basis but were up 4% organically to $4.4 billion.
You may also be interested in...
As European industry’s concerns grow about “politicization” of regulatory programs, the United States-Mexico-Canada Agreement’s cosmetics annex directs regulatory authorities pursuing new rules to give due consideration to scientific and technical guidance documents developed through international collaboration.
Canada has agreed to end its practice of quarantining and retesting certain cosmetic-OTC drug products from the US, as part of a cosmetics-specific annex to the United States-Mexico-Canada Agreement. “There will be a very significant and immediate benefit to US exporters of OTC products to Canada,” a Personal Care Products Council exec said.
There are signs of progress in US trade relations and tariff disputes in the EU and China, but visibility is never assured under the administration of President Donald Trump in a volatile global climate.